Tel：
(86)(21)60969600
Add: Building 28, Lane 588, Tianxiong Road. Shanghai, P. R. China
Shanghai, China – November 23, 2025 — Shanghai MicroPort EP MedTech Co., Ltd. (hereinafter referred to as "MicroPort EP") has announced the approval and launch of the PulseMagic™ TrueForce™, a single-use pressure-sensing pulsed field ablation catheter, by China's National Medical Products Administration (NMPA). This new device expands MicroPort EP's non-thermal ablation portfolio and marks a further step in the company's development of a platform integrating cryoablation, radiofrequency (RF), and pulsed field energy.
PulseMagic™ TrueForce™ is the first PFA catheter in its class in China equipped with both real-time pressure sensing and saline irrigation. The catheter is designed for use with MicroPort EP's Columbus™ 3D EP Navigation System, supporting controlled, consistent, and targeted ablation procedures.
Key features of the PulseMagic™ TrueForce™ catheter include:
Real-time pressure monitoring using strain gauge sensor technology to ensure stable catheter-tissue contact.
Saline irrigation to support uniform energy delivery and lesion consistency.
Integration with Columbus™ 3D mapping for procedural visualization and improved workflow.
Streamlined usability with an interface and handling experience consistent with the FireMagic™ TrueForce™ RF catheter, helping to shorten the learning curve for physicians.
The product combines multiple technologies, pulsed field ablation, magnetic navigation, and pressure feedback, to provide physicians with greater precision and control during electrophysiology procedures.
Dr. Yiyong Sun, President of MicroPort EP, commented:“By introducing pressure sensing and visualization to the pulsed field ablation pathway, PulseMagic™ TrueForce™ enhances precision and consistency in non-thermal cardiac ablation procedures. This is an important step in expanding our electrophysiology platform.”
MicroPort EP continues to invest in R&D to build a scalable and innovative ecosystem across the three leading energy modalities, cryothermal, radiofrequency, and pulsed field, to deliver integrated interventional solutions for electrophysiology.
